Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Prem Aggarwal

Dr Prem Aggarwal, (MD Medicine, DNB Cardiology) is a Cardiologist by profession and also the Co-founder and Chairman of Medical Dialogues. He focuses on news and perspectives about cardiology, and medicine related developments at Medical Dialogues. He can be reached out at drprem@medicaldialogues.in

Home

Prem Aggarwal

Articles By : Prem Aggarwal

Smoking More Than Doubles Risk of Aortic Dissection, But Quitting Slashes Risk, Study Finds

Prem Aggarwal11 Jun 2025 8:15 AM IST

Norway: A new analysis of UK Biobank data, supported by a meta-analysis of prospective studies, has confirmed a strong association between tobacco...

Invasive Versus Conservative Strategy in NSTEMI

Invasive Strategy Offers No Added Benefit in Low-Risk SCAD Patients and Raises Bleeding Risk: Study Finds

Prem Aggarwal10 Jun 2025 9:30 PM IST

China: A recent risk-stratification-based study has brought new insight into managing stable coronary artery disease (SCAD), highlighting that an...

Early Combination Therapy with add on ezitamide Should Be Standard in lipid lowering therapy after MI: Study

Prem Aggarwal10 Jun 2025 9:00 AM IST

MI care pathways should adopt early combination therapy with statins and ezetimibe as standard practice. Delaying this approach or relying solely on...

New Study Backs AHA PREVENT Equations, Highlights Added Value of Lipoprotein(a) in Predicting Heart Risk

Prem Aggarwal9 Jun 2025 8:15 AM IST

USA: A new large-scale analysis has validated the effectiveness of the American Heart Association's (AHA) recently developed PREVENT equations in...

HHS panel recommend statins for adults with HIV at risk for cardiovascular disease

Prem Aggarwal8 Jun 2025 9:00 PM IST

In February 2024, the U.S. Department of Health and Human Services Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (ARV...

High-Volume Exercise Linked to Higher Heart Disease Risk in Men, Not Women: Study

Prem Aggarwal7 Jun 2025 8:00 AM IST

USA: Recent findings suggest that high-volume endurance exercise is associated with a higher coronary artery calcium (CAC) score in men, indicating an...

Type 2 Diabetes Patients With Coronary Disease Face Higher Mortality, Poorer Right Ventricular Function: Study Shows

Prem Aggarwal6 Jun 2025 12:30 PM IST

China: Patients living with type 2 diabetes mellitus (T2DM) who also suffer from obstructive coronary artery disease (OCAD) are at a significantly...

PAD Patients with ESRD Face Higher Cardiovascular Risks After Endovascular Therapy: Study Finds

Prem Aggarwal4 Jun 2025 8:45 AM IST

Taiwan: Patients living with both peripheral artery disease (PAD) and end-stage renal disease (ESRD) face a significantly higher risk of adverse...

Biannual Injection of zilebesiran Shows Promising Blood Pressure Control In clinical trial: JAMA

Prem Aggarwal30 May 2025 9:00 AM IST

Results from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that giving people with high...

FDA Approves Abbott's Tendyne TMVR System for Mitral Valve Disease

Prem Aggarwal30 May 2025 8:30 AM IST

The US Food and Drug Administration has approved Abbott's Tendyne Transcatheter Mitral Valve Replacement (TMVR) system. It is indicated for patients...

Stenting improves long-term survival for patients with complete blockages undergoing PCI: Study

Prem Aggarwal29 May 2025 8:30 AM IST

In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved long-term survival and...

Largest phase 3 trial of novel treatment for hypertension shows promising results

Prem Aggarwal28 May 2025 8:30 PM IST

The data from the Launch-HTN trial, announced at the 34th European Meeting on Hypertension and Cardiovascular Protection, show that lorundrostat, an...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok